Diagnosis of Peripheral Pulmonary Lesions Using Forceps and 1.1- or 1.7-mm Cryoprobes: A Randomised Trial
Respiration · 25.03.2025 · 104 (8) · 603-614
DOI: 10.1159/000545338 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Respiration, online erschienen am 25.03.2025. Verfasst von Carolin Steinack und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonology, Interventional Lung Center, University Hospital Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Lung Neoplasms, Bronchoscopy, Cryosurgery, Lung. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Lung cancer screening has increased the detection of peripheral pulmonary lesions (PPLs). Accurate diagnosis for therapy and prognosis is crucial but challenging. Our study compares the safety and efficacy of transbronchial cryobiopsy with two probe diameters and forceps biopsy.
Methods
This single-centre, investigator-initiated, open-label, randomised trial included patients with PPLs who required flexible bronchoscopy with radial endobronchial ultrasound-guided biopsy for histopathological diagnosis. Patients received a forceps biopsy and were randomly assigned to a cryobiopsy with a 1.1-mm (freezing time 7–10 s) or a 1.7-mm cryoprobe (freezing time 4–6 s), respectively. The primary outcome was the diagnostic yield; secondary outcomes included total biopsy size, the proportion of malignant tissue, artefact-free alveolar space percentage, molecular pathology of the specimen, and safety.
Results
Fifty-four patients (66.52 ± 9.81 years; 48.1% male) with a median nodule size of 24 mm (interquartile range 19–30) were included. The overall diagnostic yield was similar in the 1.1-mm and 1.7-mm groups (75.9% vs. 88.0%, p = 0.261), and the specimens obtained with the two different cryoprobes were equal in size, quality, and information about molecular pathology. There was no difference in procedural-related bleeding between the groups (p = 0.847). Compared to forceps biopsies, cryobiopsies had a superior overall diagnostic yield (75.9% vs. 48.1%, p = 0.001) and were better suited for further molecular analysis (p = 0.001).
Conclusion
The 1.1-mm and 1.7-mm cryoprobes displayed comparable diagnostic yield, ability to provide molecular pathology information, and safety. Forceps biopsy was inferior to cryobiopsy in all aspects except safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pulmonology, Interventional Lung Center, University Hospital Zurich, Zurich, Switzerland.
- Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
- Department of Internal Medicine, Spital Uster, Uster, Switzerland.
Zitieren
APA
Steinack, C., Rüschoff, J. H., Roeder, M., Vesenbeckh, S. M., Ulrich, S., Haberecker, M., Nowack, M., Kohler, M., Franzen, D. P., & Gaisl, T. (2025). Diagnosis of Peripheral Pulmonary Lesions Using Forceps and 1.1- or 1.7-mm Cryoprobes: A Randomised Trial. Respiration, 104(8), 603-614. https://doi.org/10.1159/000545338
Vancouver
Steinack C, Rüschoff JH, Roeder M, Vesenbeckh SM, Ulrich S, Haberecker M, et al. Diagnosis of Peripheral Pulmonary Lesions Using Forceps and 1.1- or 1.7-mm Cryoprobes: A Randomised Trial. Respiration. 2025;104(8):603-614. doi:10.1159/000545338
BibTeX
@article{Steinack2025,
author = {Steinack, Carolin and Rüschoff, Jan Hendrik and Roeder, Maurice and Vesenbeckh, Silvan Manuel and Ulrich, Silvia and Haberecker, Martina and Nowack, Miriam and Kohler, Malcolm and Franzen, Daniel P and Gaisl, Thomas},
title = {Diagnosis of Peripheral Pulmonary Lesions Using Forceps and 1.1- or 1.7-mm Cryoprobes: A Randomised Trial},
journal = {Respiration},
year = {2025},
volume = {104},
number = {8},
pages = {603--614},
doi = {10.1159/000545338}
}
EUVIMED